Banner University Medical Center Tucson
Tucson, Arizona, 85724, United States
NCT Number: NCT05295225
This research project is intended to understand the mechanisms of action for the pain-relieving properties of visual green light exposure.
The investigators have shown previously that greenlight exposure decreased acute and chronic pain in both animals and humans. However, the investigators do not yet understand how green light exposure is capable of such function.
This study is active but is not currently recruiting participants.
18 year–50 year
All sexes
Interventional
Not applicable
Tucson, Arizona, 85724, United States
Pain is a biological function. There are several pain centers in the brain that modulate the intensity of the pain signal perceived by the brain. Part of the modulations takes place through two separate pathways. The first pathway mediates pain signals and is known as the ascending facilitator pain pathway. The main function of this pathway is to relay the pain signal to the brain to be processed.
The second pathway is known as the descending inhibitory pain pathway. The main function of this pathway is to inhibit the pain signal mediated by the first pathway.
Normal humans typically have a balance between the activities of the ascending and descending pain pathways.
The investigator animal studies suggest that green light therapy exhibits its pain-relieving effects through altering the balance between the ascending and descending pain pathway in a manner to result in an overall reduction or normalization in pain perception.
To test this hypothesis, the investigators propose recruiting 30 healthy human volunteers. The participants will be equally randomized into either green light (treatment) or white light (control) exposure groups. The investigators will initially test the activities of the ascending and descending pathways using thermal and mechanical stimulations. The investigators will also test brain wave activities using a non-invasive EEG device. After establishing the baseline activities of the pain pathways and brain waves, the volunteers will be exposed to the green light or white light at low intensity (4-100 lux) for two hours in our laboratory. After two hours of light exposure, the investigators will again test the activities of the pain pathways using thermal and mechanical stimulation and measure the brain wave EEG activities.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
GLED exposure for two hours
Other names: GLED
WLED exposure for two hours
Other names: WLED
Time frame: Two hours
Changes in activity of the ascending pain pathway
Time frame: Two hours
Changes in activity of the descending pain pathway
Time frame: Two hours
Changes in the baseline of Delta waves of EEG
Time frame: Two hours
Changes in the baseline of Theta waves of EEG
Time frame: Two hours
Changes in the baseline of Alpha waves of EEG
Time frame: Two hours
Changes in the baseline of Sigma waves of EEG
Time frame: Two hours
Changes in the baseline of Beta waves of EEG
University of Arizona
Other
Investigating the Analgesic Effects of Green Light Exposure in Normal Human Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07037992
Chronic Pain, Laparoscopic Donor Nephrectomy
Jakarta Pusat, Jakarta Special Capital Region, Indonesia
View Trial DetailsNCT05299294
Chronic Pain, Nervous System Diseases
Angers, France
View Trial DetailsNCT05503173
Agnosia, Chronic Pain
Boston, Massachusetts, United States
View Trial DetailsNCT06720909
Chronic Pain, Neurologic Manifestations
Phoenix, Arizona, United States
View Trial Details